antipyrine has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abrahamsson, B; Knutson, L; Knutson, TW; Lennernäs, H; Lindahl, A; Sandström, R; Ungell, AL | 1 |
Fagerholm, U; Lennernäs, H; Lindahl, A | 1 |
Lennernäs, H; Lindahl, A; Sandström, R; Ungell, AL | 1 |
Echizen, H; Oishi, K; Uchida, M; Yamaguchi, T | 1 |
Aoki, E; Araki, T; Kato, H; Yano, R; Yokoyama, H | 1 |
5 other study(ies) available for antipyrine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
Jejunal permeability and hepatic extraction of fluvastatin in humans.
Topics: Adult; Antipyrine; Atenolol; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Infusions, Intravenous; Intestinal Absorption; Jejunum; Liver; Male; Metoprolol; Perfusion | 1996 |
Regional intestinal permeability in rats of compounds with different physicochemical properties and transport mechanisms.
Topics: Administration, Oral; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antihypertensive Agents; Antipyrine; Atenolol; Biological Transport; Colon; Fatty Acids, Monounsaturated; Fluvastatin; Glucose; Hydrogen-Ion Concentration; Ileum; Indoles; Intestinal Absorption; Jejunum; Levodopa; Membrane Fluidity; Metoprolol; Naproxen; Perfusion; Permeability; Rats; Stereoisomerism; Structure-Activity Relationship | 1997 |
Concentration- and region-dependent intestinal permeability of fluvastatin in the rat.
Topics: Animals; Antipyrine; Biological Transport; Colon; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Glucose; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ileum; Indoles; Intestinal Absorption; Intestinal Mucosa; Jejunum; Lovastatin; Male; Rats; Rats, Sprague-Dawley | 1998 |
Edaravone, a radical scavenger, may enhance or produce antiproliferative effects of fluvastatin, amlodipine, ozagrel, GF109203X and Y27632 on cultured basilar artery smooth muscle cells.
Topics: Amides; Amlodipine; Animals; Antipyrine; Arteriosclerosis; Basilar Artery; Cell Division; Cell Survival; Cells, Cultured; Drug Synergism; Drug Therapy, Combination; Edaravone; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Free Radical Scavengers; Indoles; Maleimides; Methacrylates; Muscle, Smooth, Vascular; Pyridines; Reactive Oxygen Species; Signal Transduction; Tetrazolium Salts; Thiazoles | 2003 |
Comparative pharmacological study of free radical scavenger, nitric oxide synthase inhibitor, nitric oxide synthase activator and cyclooxygenase inhibitor against MPTP neurotoxicity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipyrine; Cyclooxygenase Inhibitors; Dopamine; Edaravone; Enzyme Activators; Enzyme Inhibitors; Etodolac; Fatty Acids, Monounsaturated; Fluvastatin; Free Radical Scavengers; Homovanillic Acid; Indazoles; Indoles; Indomethacin; Male; Mice; Mice, Inbred C57BL; Minocycline; MPTP Poisoning; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Quinolines | 2008 |